Professor of Coagulation Medicine
Department of Hematology, Coagulation Disorders Unit, and Research Program Unit in Systems Oncology Oncosys, Medical Faculty, University of Helsinki, Finland
Helsinki, Uusimaa, Finland
Riitta Lassila, MD, PhD,Professor of Coagulation Medicine, University of Helsinki, Finland, Faculty of Medicine and Research Program Unit in Systems Oncology is engaged with clinical and translational studies, including outcome biomarkers and new treatment modalities of Coagulation disorders. She is the Chair of the Finnish Blood Diseases Research Foundation. Dr. Lassila has served as secretary of the executive board of European Association of Haemophilia and Allied Disorders, EAHAD and its safety surveillance system, EUHASS. Sheis a consult for EMA, FiMEA, Finnish Medicolegal affairs in Valvira, Institute of Health and Welfare in Finland (THL) and World Health Organisation (WHO). She has served as an associate editor in Thrombosis Research and Journal of Thrombosis Haemostasis. Dr. Lassila is nominated in the ACPC of ISTH and the clinical chair of ISTH 2025 meeting. Dr. Lassila has authored over 350 articles in scientific peer-review journals.
Sunday, June 23, 2024
13:45 – 14:45 ICT
OC 34.6 - Clinical significance of biomarkers and NETs in thromboinflammation
Monday, June 24, 2024
09:30 – 10:45 ICT
OC 64.6 - Novel mechanisms and therapeutic approaches in atherothrombosis
Tuesday, June 25, 2024
14:45 – 16:00 ICT
Wednesday, June 26, 2024
10:45 – 11:00 ICT